Given the recent cases of acute respiratory illness from vaping reported in the US recently, we fully support any measures that will ensure the safety of those consumers who use vaping liquids and devices. As the distributor of Vype vaping products across Canada, Imperial Tobacco Canada takes consumer safety responsibilities very seriously.
Although investigators in the USA have not yet finally determined the cause of all of the recently reported cases, the US Food and Drug Administration is warning that there appears to be a particular danger for people who have bought vaping products on the street (i.e. not sourced from a reputable manufacturer), and for those who vape liquids with oils containing THC or containing an additive called “Vitamin E Acetate”.
Our parent company, British American Tobacco (BAT), has invested billions of dollars in the research and development of their potentially reduced risk products and the ingredients and components used in these products have been scrutinised by the BAT team of 50 toxicologists for their suitability for vaping.
To the best of our knowledge, no Vype products have been identified in any of the US reports to date. We can confirm that oils containing THC and Vitamin E Acetate are not, and have never been, added to our Vype products.
As for the one possible case in Canada, few details have been shared and authorities have not contacted us about it, which suggests it does not involve our product.
The US Food and Drug Administration (FDA) warns public to stop using Tetrahydrocannabinol (THC)-containing vaping products and any vaping products obtained off the street.
The FDA has issued a recent important consumer guidance on recent vaping illnesses dated 4th October 2019 entitled, “FDA warns public to stop using Tetrahydrocannabinol (THC)-containing vaping products and any vaping products obtained off the street."
Please see the full text of that consumer guidance by clicking the link here.